Associated Papers
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study.
Di Natale D et al.
Brain Sciences, 2025
40002499 (PubMed )
Supplement: brainsci-15-00166-s001.zip › brainsci-3430399-supplementary › Supplementary_table_S1.pdf
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study.
Mignani R et al.
Orphanet Journal of Rare Diseases, 2024
Macular Impairment in Fabry Disease: A Morpho-functional Assessment by Swept-Source OCT Angiography and Focal Electroretinography.
Minnella AM et al.
Investigative Ophthalmology & Visual Science, 2019
Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ.
Ferri L et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2018
Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin.
Graziani F et al.
European Journal of Case Reports in Internal Medicine, 2017
The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.
Verrecchia E et al.
European Journal of Internal Medicine, 2016
Select a paper to view details